These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 35475465)

  • 21. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
    Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S
    Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathologic Diagnosis of Nonalcoholic Fatty Liver Disease.
    Lai J; Wang HL; Zhang X; Wang H; Liu X
    Arch Pathol Lab Med; 2022 Aug; 146(8):940-946. PubMed ID: 34871361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of a Diet-Induced Mouse Model of Nonalcoholic Fatty Liver Disease.
    Asgharpour A; Sanyal AJ
    Methods Mol Biol; 2022; 2455():19-30. PubMed ID: 35212982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling Diet-Induced NAFLD and NASH in Rats: A Comprehensive Review.
    Carreres L; Jílková ZM; Vial G; Marche PN; Decaens T; Lerat H
    Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33918467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variation in diagnostic NAFLD/NASH read-outs in paired liver samples from rodent models.
    Jensen VS; Tveden-Nyborg P; Zacho-Rasmussen C; Quaade ML; Ipsen DH; Hvid H; Fledelius C; Wulff EM; Lykkesfeldt J
    J Pharmacol Toxicol Methods; 2020; 101():106651. PubMed ID: 31733366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted Nutrient Modifications in Purified Diets Differentially Affect Nonalcoholic Fatty Liver Disease and Metabolic Disease Development in Rodent Models.
    Radhakrishnan S; Ke JY; Pellizzon MA
    Curr Dev Nutr; 2020 Jun; 4(6):nzaa078. PubMed ID: 32494762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental models of non-alcoholic fatty liver disease in rats.
    Kucera O; Cervinkova Z
    World J Gastroenterol; 2014 Jul; 20(26):8364-76. PubMed ID: 25024595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin B5 and N-Acetylcysteine in Nonalcoholic Steatohepatitis: A Preclinical Study in a Dietary Mouse Model.
    Machado MV; Kruger L; Jewell ML; Michelotti GA; Pereira Tde A; Xie G; Moylan CA; Diehl AM
    Dig Dis Sci; 2016 Jan; 61(1):137-48. PubMed ID: 26403427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Animal Models of Fibrosis in Nonalcoholic Steatohepatitis: Do They Reflect Human Disease?
    Ipsen DH; Lykkesfeldt J; Tveden-Nyborg P
    Adv Nutr; 2020 Nov; 11(6):1696-1711. PubMed ID: 33191435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis.
    Younossi ZM; Loomba R; Anstee QM; Rinella ME; Bugianesi E; Marchesini G; Neuschwander-Tetri BA; Serfaty L; Negro F; Caldwell SH; Ratziu V; Corey KE; Friedman SL; Abdelmalek MF; Harrison SA; Sanyal AJ; Lavine JE; Mathurin P; Charlton MR; Goodman ZD; Chalasani NP; Kowdley KV; George J; Lindor K
    Hepatology; 2018 Jul; 68(1):349-360. PubMed ID: 29222917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonalcoholic-Fatty-Liver-Disease and Nonalcoholic Steatohepatitis: Successful Development of Pharmacological Treatment Will Depend on Translational Research.
    Gottlieb A; Mosthael W; Sowa JP; Canbay A
    Digestion; 2019; 100(2):79-85. PubMed ID: 30537758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients.
    Teufel A; Itzel T; Erhart W; Brosch M; Wang XY; Kim YO; von Schönfels W; Herrmann A; Brückner S; Stickel F; Dufour JF; Chavakis T; Hellerbrand C; Spang R; Maass T; Becker T; Schreiber S; Schafmayer C; Schuppan D; Hampe J
    Gastroenterology; 2016 Sep; 151(3):513-525.e0. PubMed ID: 27318147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive Study of Multiple Stages Progressing to Nonalcoholic Steatohepatitis with Subsequent Fibrosis in SD Rats.
    Wang L; Wu S; Cai M; Ma J; Li S; Li M; Xu Y; Wei L; Shang J
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28820447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
    Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Addition of trans fat and alcohol has divergent effects on atherogenic diet-induced liver injury in rodent models of steatohepatitis.
    Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Krag A; Karsdal MA; Nielsen MJ; Brockbank S; Cruwys S
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G410-G418. PubMed ID: 31905026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH.
    Morin J; Swanson TA; Rinaldi A; Boucher M; Ross T; Hirenallur-Shanthappa D
    J Vis Exp; 2021 Apr; (170):. PubMed ID: 33970131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame.
    Ibrahim SH; Hirsova P; Malhi H; Gores GJ
    Dig Dis Sci; 2016 May; 61(5):1325-36. PubMed ID: 26626909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporal Development of Dyslipidemia and Nonalcoholic Fatty Liver Disease (NAFLD) in Syrian Hamsters Fed a High-Fat, High-Fructose, High-Cholesterol Diet.
    Svop Jensen V; Fledelius C; Max Wulff E; Lykkesfeldt J; Hvid H
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33673227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
    Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
    J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic Steatohepatitis.
    Farrell G; Schattenberg JM; Leclercq I; Yeh MM; Goldin R; Teoh N; Schuppan D
    Hepatology; 2019 May; 69(5):2241-2257. PubMed ID: 30372785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.